Caplight Directory>Companies>Neurophth-preview>Neurophth


Neurophth

Neurophth

Private
Wuhan, HubeiHealthcare & Life Scienceshttps://www.neurophth.com

Last Round

Series C

Extension

Aug 11, 2023

Total Funding Raised

$237.6M

Company Overview

Neurophth is a biotechnology company specializing in gene therapies aimed at treating ophthalmological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

gene therapyAAV gene therapyophthalmic gene therapyLeber hereditary optic neuropathyLHONinherited retinal diseasesclinical-stage biotechAAV vectorin-vivo gene therapyorphan drugintravitreal injectionGMP manufacturingNR082Opvikaesonadogene mvoparvovecgenetic eye diseasesoptic neuroprotection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurophth Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurophth Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionAug 11, 2023
Series CNov 22, 2021
Series BFeb 9, 2021
Series AApr 9, 2020
AngelJul 1, 2018
View all Funding Rounds

Key People

Founding team and executive leadership

Su Xiao

Co-Founder, Chief Technical Operations Officer, Board Member

Founding Team

Luke Li

CEO Deputy GM Of SH SZ Branch Head Of Com Ops Director Of BoD, VP, Strategy, BD Alliances, GA And Commercialization Deputy GM, Neurophth Shanghai Branch

Executive Team

Neurophth Investors

Notable investors and investment history

InvestorRounds
Huaxin Investment China InnoVision CapitalSeries B
Oriza HoldingsSeries B
Northern Light Venture CapitalAngel, Series B, Series A
InnoVision CapitalSeries B
Shanghai International GroupSeries B
Yangtze River Industry FundSeries C Extension
BOHE Angel FundAngel
View all Investors

Neurophth Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurophth Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurophth's valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan, Hubei
Employee Range39
Year Founded2016
Last FundingAug 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.